Evolution Metals & Technologies Corp. EMAT Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

MacerichMAC

$5.23M+4,335%

ServiceTitan, Inc.TTAN

$348.97K—

UDRUDR

$3.35M+50.9%

AESAES

$0—

Mirum Pharmaceuticals, Inc.MIRM

$0-100%

Oscar HealthOSCR

$70.83M—

Revenue$1.9M—

Gross profit$445.0K—

Operating income-$15.7M-459%

Net income-$440.3M-2,347%

EPS (diluted)-$0.72-1,700%

Cash & equivalents$5.4M+44.7%

Total debt$6.8M—

Total equity-$24.8M-118%

Total assets$85.6M+592%

Operating cash flow-$5.6M-170%

CapEx$24.0K—

Free cash flow-$5.6M—

Market cap$4.41B—

Current ratio0.1×+0.1×

Reported directly by Evolution Metals & Technologies Corp. in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: Evolution Metals & Technologies Corp. ’s 10-Q, filed May 22, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Evolution Metals & Technologies Corp. 's exchange offer (note 12)?: Evolution Metals & Technologies Corp. (EMAT) reported exchange offer (note 12) of $3.08M in Q1 2026.